This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on ISI (1)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Hypertension  • Diabetic Retinopathy  • Alert me on articles by topic

Arch Ophthalmol. 2004;122:1707-1709.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The Diabetic Retinopathy Study showed the efficacy of panretinal photocoagulation in preventing severe loss of vision in persons with proliferative diabetic retinopathy.¹ The Early Treatment Diabetic Retinopathy Study (ETDRS) showed that focal and grid laser photocoagulation reduced the incidence of significant visual loss of 3 lines or more due to diabetic macular edema.² While photocoagulation prevents loss of vision in many persons with diabetes, it is not without costs and complications, and may not always prevent the progression of disease or loss of vision.³ More recently, there has been interest in new surgical interventions, such as intravitreal injections of steroids and anti–vascular endothelial growth factors, to treat eyes with diabetic macular edema and proliferative diabetic retinopathy.⁴ These surgical interventions should be thought of as a tertiary prevention of more advanced complications associated with diabetic retinopathy.

A better strategy, in the absence of primary prevention of diabetes itself, is the prevention . . . [Full Text of this Article]

AUTHOR INFORMATION
Ronald Klein, MD, MPH

RELATED ARTICLE

Risks of Progression of Retinopathy and Vision Loss Related to Tight Blood Pressure Control in Type 2 Diabetes Mellitus: UKPDS 69
UK Prospective Diabetes Study (UKPDS) Group
Arch Ophthalmol. 2004;122(11):1631-1640.
ABSTRACT | FULL TEXT